logo
#

Latest news with #Atomico

Hinge Health pops 17%, but joins growing ranks of down-round IPOs
Hinge Health pops 17%, but joins growing ranks of down-round IPOs

Yahoo

time23-05-2025

  • Business
  • Yahoo

Hinge Health pops 17%, but joins growing ranks of down-round IPOs

Hinge Health, a digital physical therapy company, closed its first day of trading on the New York Stock Exchange on Thursday at $37.56, up about 17% over the $32 IPO price it set the previous day. That's a good first-day result. But even with the pop, Hinge's public valuation is significantly less than its last private market one. The 11-year-old company's approximate market capitalization, excluding employee options, was about $3 billion, which is less than half of the $6.2 billion Hinge attained in its October 2021 Series E funding round, which was led by Tiger Global Management. Until recently, companies went to great lengths to avoid down-round IPOs. However, the stigma associated with going public below the last private valuation has lessened significantly if that valuation was during the heady 2020-2021 era. Companies whose IPOs are priced lower than their last private valuation by VCs include Reddit, which debuted last year at about $5.4 billion, roughly half its $10 billion valuation from 2021. Another example is ServiceTitan, whose IPO valued it at about $6.3 billion, below the $7.6 billion valuation it secured in a Series H round two years earlier. Hinge Health's IPO raised $437 million, with about $237 million in proceeds going directly to the company and the remainder to its existing investors. The company's largest outside shareholders are Insight Partners, which holds 19% of all stock, and Atomico, which has 15% of all shares. Other venture capital firms that own approximately 8% of Hinge's shares include 11.2 Capital, Coatue, Tiger Global, and Bessemer Venture Partners, according to the company's latest S-1 filing. Co-founders Daniel Perez and Gabriel Mecklenburg own 18.9% and 8.2%, respectively. The company aims to reduce musculoskeletal pain with the help of wearable sensors and computer vision technology remotely monitored by a clinical care team of physical therapists, physicians, and board-certified health coaches. Omada Health, another digital health company, filed to go public earlier this month. The 13-year-old startup offers virtual care between doctors' visits for chronic conditions like diabetes and hypertension, and competes with Hinge Health in the musculoskeletal pain reduction space. Omada's biggest shareholders include U.S. Venture Partners and Andreessen Horowitz, and was last valued in 2022 at just above $1 billion. Hinge Health's primary competitor is Sword Health, which was valued at $3 billion about a year ago. At that time, Sword Health's CEO, Virgilio Bento, told TechCrunch that the company might also pursue an IPO in 2025 if it grows as expected and the macroeconomic environment is favorable. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Hinge Health pops 17%, but joins growing ranks of down round IPOs
Hinge Health pops 17%, but joins growing ranks of down round IPOs

TechCrunch

time22-05-2025

  • Business
  • TechCrunch

Hinge Health pops 17%, but joins growing ranks of down round IPOs

Hinge Health, a digital physical therapist company, closed its first day of trading on the New York Stock Exchange on Thursday at $37.56, up about 17% over the $32 IPO price it set the previous day. That's a good first-day result. But even with the pop, Hinge's public valuation is significantly less than its last private market one. The 11-year-old company's approximate market capitalization, excluding employee options, was about $3 billion, which is less than half of the $6.2 billion Hinge attained in its October 2021 Series E funding round, which was led by Tiger Global Management. Until recently, companies went to great lengths to avoid down-round IPOs. However, the stigma associated with going public below the last private valuation has lessened significantly if that valuation was during the heady 2020-2021 era. Companies whose IPOs are priced lower than their last private valuation by VCs include Reddit, which debuted last year at about $5.4 billion, roughly half its $10 billion valuation from 2021. Another example is ServiceTitan, whose IPO valued it at about $6.3 billion, below the $7.6 billion valuation it secured in a Series H round two years earlier. Hinge Health's IPO raised $437 million, with about $237 million in proceeds going directly to the company and the remainder to its existing investors. The company's largest outside shareholders are Insight Partners, which holds 19% of all stock, and Atomico, which has 15% of all shares. Other venture capital firms that own approximately 8% of Hinge's shares include 11.2 Capital, Coatue, Tiger Global, and Bessemer Venture Partners, according to the company's latest S1 filing. Co-founders Daniel Perez and Gabriel Mecklenburg own 18.9% and 8.2%, respectively. The company aims to reduce musculoskeletal pain with the help of wearable sensors and computer vision technology remotely monitored by a clinical care team of physical therapists, physicians, and board-certified health coaches. Techcrunch event Join us at TechCrunch Sessions: AI Secure your spot for our leading AI industry event with speakers from OpenAI, Anthropic, and Cohere. For a limited time, tickets are just $292 for an entire day of expert talks, workshops, and potent networking. Exhibit at TechCrunch Sessions: AI Secure your spot at TC Sessions: AI and show 1,200+ decision-makers what you've built — without the big spend. Available through May 9 or while tables last. Berkeley, CA | REGISTER NOW Omada Health, another digital health company, filed to go public earlier this month. The 13-year-old startup offers virtual care between doctors' visits for chronic conditions like diabetes and hypertension and competes with Hinge Health in the musculoskeletal pain reduction space. Omada's biggest shareholders include U.S. Venture Partners and Andreessen Horowitz, which was last valued in 2022 at just above $1 billion. Hinge Health's primary competitor is Sword Health, which was valued at $3 billion about a year ago. At that time, Sword Health's CEO, Virgilio Bento, told TechCrunch that the company might also pursue an IPO in 2025 if it grows as expected and the macroeconomic environment is favorable.

Job&Talent raises EUR 92 million funding to accelerate AI-powered growth
Job&Talent raises EUR 92 million funding to accelerate AI-powered growth

Yahoo

time10-04-2025

  • Business
  • Yahoo

Job&Talent raises EUR 92 million funding to accelerate AI-powered growth

Job&Talent's AI agents Job&Talent's Madrid headquarters The funding round was backed by a powerful lineup of investors - including Atomico, BlackRock, DN Capital, Hercules, Infravia, Kibo, and Kinnevik. The funds will be used to drive international expansion, scale sales, and accelerate product development - with a strong focus on AI-powered features and automation. Job&Talent is now leveraging its AI-driven platform to deliver measurable productivity gains for clients and set new standards in workforce management. MADRID, April 10, 2025 (GLOBE NEWSWIRE) -- Job&Talent, a world-leading marketplace for essential work and AI-powered workforce management provider, today announces the successful closing of its Series F fundraising round, securing EUR 92 million in equity financing to accelerate the next generation of workforce management. The round, which values the company at EUR 1.3 billion, included participation from new and existing investors such as Atomico, BlackRock, DN Capital, Hercules, Infravia, Kibo, and Kinnevik among others. This new funding will fuel Job&Talent's long-term strategic goals, including accelerating international growth and major advances in AI-powered technology. The company will invest heavily in sales and product development, with a strong focus on expanding its AI capabilities to enhance workforce reliability and productivity for clients. As part of its innovation strategy, Job&Talent is developing a suite of AI agents, each designed to simplify and optimize a specific aspect of workforce management, supporting candidates, workers, and supervisors alike. These intelligent agents are trained using invaluable operational data from over 1 million worker placements and millions of logged shifts across the platform, including performance metrics, shift management, absenteeism, and more. The AI agents—whose expertise ranges from recruiter to account manager and attendance coach—work across text, voice, and video to automate repetitive and time-consuming tasks, as well as proactively supporting employers to hire more efficiently, manage their workforce with greater control, and significantly reduce operational costs. For example, agents can call unlimited candidates within minutes of application, anticipate staffing needs and automate shift planning, and proactively manage attendance by detecting no-shows in real-time. The first AI agent launched was Clara, Job&Talent's recruitment agent. Currently being tested with select clients, Clara has already conducted over 180,000 interviews in just a few months, equivalent to the output of thousands of recruiters, and has directly contributed to more than 7,000 hires, helping deliver industry-leading fill rates, even during peak periods of demand. With multiple agents already in beta testing, the company plans to launch more agents throughout the year to address different areas of workforce management. This year, the company will also expand access to its platform and AI agents to include permanent workers, enabling companies to benefit from its capabilities and cost savings across their entire workforce — not just those staffed by Job&Talent. The rollout is starting with select existing clients and will be available to all companies in the second half of the year. With this expansion, Job&Talent extends its value proposition to the entire frontline workforce, offering companies the flexibility to seamlessly hire and manage both temporary and permanent workers through a single, integrated platform. Over the past two years, Job&Talent has successfully navigated a challenging macroeconomic environment by prioritizing profitability, operational efficiency, and product innovation. In 2024 alone, Job&Talent placed over 300,000 workers globally in more than 3,250 companies in key sectors such as logistics, warehousing, and retail. Since launching in 2021, the US has steadily grown to become Job&Talent's largest and fastest-growing market, demonstrating a +27% YoY revenue increase in Q4 2024. This growth was driven by a nation-wide rollout of its technology-driven workforce management platform. Earlier this year, the company expanded platform availability to all 10 countries in which it operates, reinforcing its global footprint. Juan Urdiales, Co-Founder and Co-CEO at Job&Talent, said: 'This capital injection reaffirms our shared vision for the future of Job&Talent. Thanks to the platform we have built over the past years, we are now well-positioned to evolve into a fully integrated employment platform that helps companies manage their temporary and internal workforces more efficiently. Our next-generation AI agents will bring major improvements in productivity, provide better opportunities for workers, and unlock crucial cost savings for companies.' MEDIA CONTACTKingsum LiSenior Manager, Global Communicationspress@ ABOUT JOB&TALENTJob&Talent is a world-leading marketplace for essential work, matching great people with great companies directly through its platform. Founded in 2009, its mission is to empower workers by offering stability, faster job placements and fair treatment, while supporting companies with efficient workforce management solutions. The AI-enabled platform streamlines and automates workforce management, helping businesses achieve higher productivity and workforce reliability. In 2024, Job&Talent placed over 300,000 workers in more than 3,250 companies across industries like logistics and retail. Headquartered in Madrid, Job&Talent operates in 10 countries across Europe, the U.S., and Latin America, backed by leading investors such as Atomico, Kinnevik and SoftBank. For more information, please visit Photos accompanying this announcement are available at: in to access your portfolio

TravelPerk Raises $200M and Acquires Yokoy to Create the Leading Integrated Travel and Expense Management Platform
TravelPerk Raises $200M and Acquires Yokoy to Create the Leading Integrated Travel and Expense Management Platform

Yahoo

time28-01-2025

  • Business
  • Yahoo

TravelPerk Raises $200M and Acquires Yokoy to Create the Leading Integrated Travel and Expense Management Platform

The acquisition of Yokoy, a leading spend management platform, allows TravelPerk to offer a deeper and more unified travel and expense offering to its clients while expanding its addressable opportunity. The $200m Series E financing raises the company's valuation to $2.7 billion. It will accelerate TravelPerk's continued expansion into the US alongside further investments into product and AI. Atomico, EQT Growth, Noteus Partners and Sequoia Capital will join TravelPerk's world-class investor base alongside existing investors like General Catalyst, Kinnevik, Softbank Vision Fund, and Spain and ZURICH, Jan. 28, 2025 (GLOBE NEWSWIRE) -- TravelPerk, the leading business travel platform, today announces a new Series E fundraise of $200m. The investment is led by European venture capital firm Atomico, alongside EQT Growth, with significant participation from Noteus Partners and existing investors, including Kinnevik and General Catalyst. The oversubscribed round nearly doubles TravelPerk's valuation to $2.7 billion. The funding will be used to further accelerate growth - with continued expansion into the US market (following the acquisition of AmTrav in 2024) alongside significant investments into product, technology and AI to deliver the leading travel and expense management platform for SMB and mid-market companies in the U.S. and Europe. The company also announced today its acquisition of Yokoy, market-leader in Europe for AI-powered expense, invoice, and card payment processing. As companies face greater economic pressures and more complicated regulatory environments, they are increasingly demanding a fully integrated solution that brings travel and expenses together into one automated platform, to simplify the end-to-end experience, streamline processes, and help them better control costs. Through its acquisition of Yokoy, and deep integrations via an open ecosystem of strategic expense management partners, TravelPerk is positioned to provide customers in Europe and the US highly localized solutions, to suit their individual needs, preserving customers freedom of choice and flexibility, which is a key tenet of the TravelPerk value proposition. 'Until now, customers had to make hard trade-offs— an integrated solution or best-in-class travel and expense solutions. A platform delivering a great end-user experience or one focused on the experience for Finance,' commented TravelPerk President and Chief Operating Officer, JC Taunay-Bucalo, adding: 'Customers don't have to compromise anymore. Now, they can have the best travel management product built on the world's largest inventory, and the expense management product that works best for their business, combined for the best integrated experience there is.' TravelPerk and Yokoy have collaborated since 2020, successfully partnering to jointly offer travel and expense management to customers such as Breitling, On Running, and Medskin. Philippe Sahli, Co-founder and CEO of Yokoy, commented: 'Given our successful collaboration to-date, and the compelling vision for the future of integrated travel and expense management, we are excited to come together as one company and are confident in the unprecedented experience we can together deliver to customers.' The acquisition of Yokoy and Series E funding came off the back of another year of growth at TravelPerk. The company has achieved a unique combination of growth and profitability at scale - with annualized booking volumes of over $2.5 billion, annualized revenue of over $200 million, growth of over 50% per annum in the last two years, and reaching EBITDA break-even at the end of 2024. Avi Meir, TravelPerk CEO and Co-Founder, commented: "Our focus has never been stronger as we expand across core markets, accelerate growth in the US, and now work to become the number one travel and expense management platform.' He continued: "Our partnership with Yokoy has already been a great success, and we are excited to take it to the next level by welcoming Phil, Devis, and the rest of the team to TravelPerk. We share a common vision for the role of AI reshaping the future of travel and expense management, and the innovation coming out of Yokoy's AI labs in Zurich is seriously impressive.' Hillary Ball, Partner at Atomico, who will join TravelPerk's Board of Directors, commented: 'Corporate travel and expense management is time-consuming, expensive and burdensome. We've long admired how TravelPerk has solved this problem with a product-centric approach, and remained at the forefront of the market through strategic acquisitions, international growth, and innovative product expansions. Yet, with a team as ambitious as TravelPerk, and with the inclusion of Yokoy, there is still so much more on the horizon. Atomico is thrilled to be partnering with Avi and the whole team to fuel the next phase of the company's vision.' Carolina Brochado, Partner at EQT Growth, who will also join the Board, commented: "Having followed the TravelPerk team for years, we've been consistently impressed by their focus, tenacity, and ambition in disrupting the industry. Their proprietary use of AI is among the best we've seen, enabling faster, smarter service for their customers. With the Yokoy acquisition, their product evolves into a true end-to-end T&E solution, further powered by AI."Yokoy was acquired in an all-equity deal, with Sequoia Capital, the prominent American venture capital firm, now joining TravelPerk's cap table alongside its existing investors. About TravelPerk TravelPerk is a hyper-growth SaaS business travel platform and a pioneer in the future of travel for work. Its all-in-one platform gives travelers the freedom they want whilst providing companies with the control they need. The result saves time, money, and hassle for everyone. TravelPerk has industry-leading travel inventory alongside powerful management features, 24/7 customer support, state-of-the-art technology, and consumer-grade design, which enable companies and organizations worldwide like Red Bull, GetYourGuide, and Aesop, to get the most out of their travel. Visit for more information. About Yokoy Yokoy is the Intelligent Spend Management Platform, founded in Switzerland in 2019 with the aim of streamlining and simplifying how businesses process expenses, invoices, and card payments. Powered by its proprietary AI, Yokoy is trusted by more than 700 customers around the world to automate their finance processes and accelerate the move towards zero-touch spend management. Yokoy was named #1 fastest-growing B2B Fintech brand in Europe by Sifted in 2024. Visit for more information. Media contact: Press office - press@ A photo accompanying this announcement is available at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store